New strategies for management of malnutrition in peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 20, Issue 3, 2000, Pages 271-275

  Stenvinkel, P ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; LEPTIN; RECEPTOR BLOCKING AGENT; RECOMBINANT GROWTH HORMONE; RECOMBINANT SOMATOMEDIN C; SERUM ALBUMIN; THALIDOMIDE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADIPOSE TISSUE; ALBUMIN BLOOD LEVEL; ANOREXIA; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; COMORBIDITY; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE CLASSIFICATION; EDITORIAL; FOOD INTAKE; HEART MUSCLE CONTRACTILITY; HEMODIALYSIS PATIENT; HUMAN; HYPOALBUMINEMIA; INFLAMMATION; LEAN BODY WEIGHT; LONG TERM CARE; MALNUTRITION; MORTALITY; MUSCLE ATROPHY; NUTRITIONAL STATUS; PERITONEAL DIALYSIS; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN DEGRADATION; PROTEIN SYNTHESIS;

EID: 0033941475     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080002000301     Document Type: Editorial

References (45)

1. Nutrition and adequacy of dialysis. How do hemodialysis and CAPD compare?
2. Nutritional status of patients on hemodialysis and peritoneal dialysis
3. Nutritional assessment of continuous ambulatory peritoneal dialysis patients: An international study
4. What really happens to people on long-term peritoneal dialysis?
5. Body composition in patients treated with peritoneal dialysis
6. An analysis of the effects of increasing delivered dialysis treatment to malnourished peritoneal dialysis patients
7. Increases in serum leptin during peritoneal dialysis are associated with inflammation and a decrease in lean body mass
8. Predictors of survival in continuous ambulatory peritoneal dialysis patients: A five-year prospective study
9. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival
10. Are there two types of malnutrition in chronic renal failure? Evidence for relationships between malnutrition, inflammation and atherosclerosis (MIA syndrome)
11. Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients
12. C-Reactive protein as an outcome predictor for maintenance hemodialysis patients
13. Inflammation enhances cardiovascular risk and mortality in hemodialysis patients
14. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy
15. Inflammation, aspirin and the risk of cardiovascular disease in apparently healthy men
16. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients
17. Serum C-reactive protein (CRP) and risk of death in chronic dialysis patients
18. Serum C-reactive protein: A predictor of mortality in continous ambulatory peritoneal dialysis patients
19. Strong associations between malnutrition, inflammation and atherosclerosis in chronic renal failure
20. High serum hyaluronan indicate poor survival in renal replacement therapy
21. Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients
22. Immunologic function and survival in hemodialysis patients
23. Malnutrition, cardiac disease and mortality - an integrated point of view
24. Cytokines and anorexia: A brief overview
25. Interleukin-6 predicts hypoalbuminemia, hypocholesterolemia, and mortality in hemodialysis patients
26. Serum IL-6 level as an indicator of survival outcome in CAPD patients
27. Treatment of malnourished CAPD patients with an amino acid based dialysate
28. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients
29. Low grade inflammatory activity abolishes the anabolic effect of growth hormone (GH) on metabolism in hemodialysis patients
30. Randomised double-blind comparison of chimeric monoclonal antibody to tumour necrosis factor alpha (cA2) versus placebo in rheumatoid arthritis
31. Effects of thalidomide on HIV-associated wasting syndrome: A randomized, double blind, placebo-controlled clinical study
32. Eating behavior in continuous ambulatory dialysis and hemodialysis patients
33. Influence of different treatment and schedules on the factors conditioning the nutritional status in dialysis patients
34. Increased plasma leptin/fat ratio in patients with chronic renal failure: A cause of malnutrition
35. Association of the serum leptin concentration with weight loss in chronic hemodialysis patients
36. Increased plasma leptin concentrations in end-stage renal disease
37. Serum leptin correlates with fat mass but not energy intake in continuous ambulatory peritoneal dialysis
38. Increase of intra-abdominal fat in patients treated with continuous ambulatory peritoneal dialysis
39. Fat tissue accumulattion during peritoneal dialysis is associated with a polymorphism in uncoupling protein 2
40. Body-mass index and mortality in a prospective cohort of US adults
41. Influence of excess weight on mortality and hospital stay in 1346 hemodialysis patients
42. Body weight-for-height relationships predict mortality and morbidity in maintenance hemodialysis patients
43. Obesity is a favorable prognostic factor in peritoneal dialysis patients